Biomerica (BMRA) Liabilities and Shareholders Equity (2011 - 2026)

Biomerica (BMRA) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 33.87% year-over-year to $4.9 million; the trailing twelve-month figure through Feb 2026 stood at $23.7 million (down 25.38% YoY), and the FY2025 full-year result was $5.9 million, down 35.76% from the prior year.
• Liabilities and Shareholders Equity declined to $4.9 million in Q1 2026, from $6.0 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $17.6 million in Q1 2022 to a low of $4.9 million in Q1 2026.
• A 5-year average of $9.6 million and a median of $9.3 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity surged 31.56% in 2022 and sank 53.25% in 2023, its largest moves.
• Tracing BMRA's Liabilities and Shareholders Equity over 5 years: stood at $9.9 million in 2022, then climbed by 19.41% to $11.8 million in 2023, then tumbled by 38.52% to $7.3 million in 2024, then slipped by 17.05% to $6.0 million in 2025, then decreased by 19.16% to $4.9 million in 2026.
• Business Quant data shows BMRA's Liabilities and Shareholders Equity at $4.9 million in Q1 2026, $6.0 million in Q4 2025, and $6.9 million in Q3 2025.